US$ 22.27
have glp 1 prices dropped Novo cuts GLP-1 70%, but semaglutide revenue could grow in 2026 New Medicare GLP-1 Bridge Program
Description
New drug approvals, innovative delivery mechanisms such as weekly injections and oral formulations, and inclusion in treatment guidelines are boosting adoption

10.1016/j.neuropharm.2023.109716 Neuropharmacology 81 WardR.LiW.AbdulY.JacksonL.DongG.JamilS.et al (2019)

"Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes." JAMA Netw Open

Note: This publication does not cover those programs in this article